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Pleiotropy refers to the capacity of a DNA mutation to 
have an eﬀ   ect on many biological systems and is a 
consequence of the fact that, during life, gene products 
are typically expressed, as so-called spatial and temporal 
eﬀ  ects, in a variety of cell types at a number of diﬀ  erent 
times. Pleiotropy of common alleles is an expected 
feature of human diseases that have a major genetic 
compo  nent and manifests as an allele associated with 
several diﬀ  erent phenotypes. Th   e musculoskeletal system 
is no exception and in the previous issue of Arthritis 
Research & Th  erapy Shi and colleagues [1] brought 
another example to our attention. In their study of Han 
Chinese, the investigators reported an association of the 
D-repeat polymorphism of the asporin gene, ASPN, with 
developmental dysplasia of the hip (DDH). Th  is 
polymorphism had originally shown an association with 
knee osteoarthritis (OA) and subsequently with lumbar-
disc degeneration (LDD), also in Asian cohorts [2,3].
Asporin is an extracellular matrix (ECM) macro  mole-
cule belonging to the small leucine-rich proteo  glycan 
(SLRP) protein family. SLRP family members are able to 
bind other structural components of the ECM, such as 
collagen, as well as growth factors that tempor  arily reside 
in the ECM, such as members of the trans  forming growth 
factor-beta (TGF-β) superfamily. Asporin is present in a 
number of tissues, including cartilage, and the D-repeat 
polymorphism of ASPN resides within exon 2 of the gene. 
It gets its name from the fact that it is a triplet repeat 
coding for a polymorphic stretch of residues of aspartic 
acid (D is the one-letter code for this particular amino 
acid). Depending on the ethnic group, the repeat has up 
to 12 alleles encoding 8 to 19 D residues.
In the original OA association study, it was reported 
that the allele coding for 14 D-repeats (D14) was a risk 
allele for knee OA [2]. Th   is was also the case for LDD [3] 
and is the case in the recent DDH study [1]. Furthermore, 
the D13 allele was found to be protective for knee OA, 
something also observed for DDH. OA and LDD can be 
viewed as having similar etiological routes, both of which 
involve degeneration of cartilage, albeit of diﬀ  erent types; 
that of OA is hyaline and that of LDD is ﬁ  brocartilage. 
Th  ey are also diseases associated with aging. However, 
DDH is not associated with aging but is instead 
congenital, nor is it a degenerative disease but instead 
involves the displace  ment of the proximal femur from the 
acetabulum.
What is particularly intriguing, therefore, is how the 
same alleles at the ASPN D-repeat contribute to pheno-
types as diﬀ   erent as OA/LDD and DDH. Functional 
studies have suggested that asporin attenuates TGF-β 
signaling and that the extent of the attenuation is 
inﬂ  uenced by the number of D-repeats [2,4,5]. Perhaps, 
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the length of the run of aspartic acids, combined with 
expected diﬀ   erences in the expression levels of the 
various members of the TGF-β superfamily during 
develop  ment and in mature tissues, inﬂ  uences  which 
skeletal sites are aﬀ  ected and which phenotypes result.
Th  e reality will obviously be far more complex than 
this. For example, being inﬂ  uenced by genotypes at other 
loci and by non-genetic factors, the association of the 
D-repeat with OA, LDD, and DDH is far from penetrant. 
Th  is is apparent when one recalls that, although the 
D-repeat can have an impact on knee OA in Asians, it 
does not contribute to knee OA in Europeans: genetic or 
non-genetic factors must account for this ethnic 
diﬀ  erence [6]. Furthermore, the D-repeat is associated 
with an aberrant hip shape that results in DDH in the 
young but is not associated with an increased risk of hip 
OA in older patients; in the latter, the eﬀ  ect on hip OA is 
presumably a temporal one.
Another example in the literature of pleiotropy of an 
OA locus is the single-nucleotide polymorphism 
rs143383, which is located in the 5’ untranslated region of 
GDF5. Th  is gene codes for the TGF-β superfamily 
member growth and diﬀ   erentiation factor 5. Like the 
ASPN D-repeat, rs143383 was ﬁ   rst reported to be 
associated with increased risk of large-joint OA, princi-
pally of the knee [7]. rs143383 was then shown to be 
associated with other joint-related disease phenotypes, 
including DDH and LDD [8-10]. Th  ere are, therefore, 
striking similarities between the D-repeat and rs143383 
associations; the obvious similarity is that when it comes 
to lower-limb OA, both variants are particularly relevant 
to knee disease, but when it comes to early development, 
the hip is the main repository of the genetic eﬀ  ect. We 
shall have to wait for the discovery of additional suscep-
tibility alleles to assess whether this shared genetic risk 
between OA, LDD, and DDH is more widespread or 
whether it is restricted to members of the TGF-β signal-
ing pathway. One thing that we can be certain of is that 
late-onset musculoskeletal diseases can inform our under-
standing of developmental conditions, and vice versa.
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